personalised medicine

Showing 15 posts of 21 posts found.


Making things personal: Roche and personalised medicine

August 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, feature, personalised medicine, pharma

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to patient …


Eli Lilly to buy Loxo Oncology in deal worth $8 billion

January 7, 2019
Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine

US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …


First-ever study in the personalised treatment of rare cancers brings promising results

October 18, 2017
Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer

The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …


Breakthrough in personalised medicine as cancer vaccine shows results

July 6, 2017
Research and Development Precision Medicine, personalised medicine, precision oncology

The old adage that everyone is unique holds a lot of water when it comes to cancer treatment. Research has …


Roche posts positive mid-stage trial results for atezolizumab

July 13, 2015
Research and Development Genentech, PD-L1, Phase II, Roche, anti-PD-L1, atezolizumab, clinical trial, immuno-oncology, personalised medicine

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …


Steve Mott joins DrugLogic

October 5, 2011
Research and Development appointment, outcomes research, personalised medicine, pharmacovigilance, research and development

Former Datapharm Communications chief executive Steve Mott has been apppointed UK managing director by DrugLogic.The US firm develops analytical tools …

First personalised asthma drug shows promise

August 4, 2011
Roche, asthma, personalised medicine

Roche’s personalised asthma drug lebrikizumab has met its primary end point in a phase II trial. Lebrikizumab increased the level …

Roche and Merck collaborate on personalised cancer tests

June 8, 2011
Research and Development Merck, Roche, personalised medicine

Roche has signed a deal to develop diagnostic tests for products in Merck’s oncology pipeline, in a bid to make …


GSK takes lead role in UK personalised medicine programme

May 20, 2011
Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …


Roche aims for wholly personalised skin cancer drug

May 12, 2011
Sales and Marketing Roche, personalised medicine, skin cancer, vemurafenib

Roche has submitted its key skin cancer drug vemurafenib to European and American regulators for approval. Vemurafenib (formerly RG7204) has …

AZ signs targeted colon cancer drug collaboration

May 11, 2011
Research and Development AstraZeneca, colorectal cancer, personalised medicine

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011
Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

AstraZeneca's Iressa (gefitinib)

AZ and Pfizer support personalised medicine database

February 8, 2011
Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine

AstraZeneca and Pfizer have teamed up with leading charity Cancer Research UK to help develop its stratified medicines programme. Stratified …

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011
Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …

Roche building

Trial success for Roche’s personalised skin cancer drug

January 19, 2011
Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer

A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …

Latest content